Defining Parameters for Successful Immunocytotherapy of Persistent Viral Infection
- 1 January 2000
- Vol. 266 (2) , 257-263
- https://doi.org/10.1006/viro.1999.0074
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T LymphocytesImmunity, 1996
- Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the DonorNew England Journal of Medicine, 1995
- An Essential Role for Type 1 Interferon-γ in Terminating Persistent Viral InfectionVirology, 1995
- Persistent infection of mice with Pichinde virus associated with failure to thriveMicrobial Pathogenesis, 1995
- CTL Escape Viral VariantsVirology, 1995
- Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.The Journal of Experimental Medicine, 1995
- Immune Responses in Interleukin-2-Deficient MiceScience, 1993
- Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cellsNature, 1993
- Cytoimitiunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous systemNature, 1986
- Genomic and Biological Variation among Commonly Used Lymphocytic Choriomeningitis Virus StrainsJournal of General Virology, 1983